We are live on ! Find out more
TVTX icon

Travere Therapeutics

138 hedge funds and large institutions have $1.42B invested in Travere Therapeutics in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 48 increasing their positions, 41 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

51% more capital invested

Capital invested by funds: $945M → $1.42B (+$478M)

27% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 22

17% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 41

3% more funds holding

Funds holding: 134138 (+4)

0.22% more ownership

Funds ownership: 102.24%102.46% (+0.22%)

22% less call options, than puts

Call options by funds: $3.51M | Put options by funds: $4.49M

Holders
138
Holders Change
+4
Holders Change %
+2.99%
% of All Funds
2.44%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
28
Increased
48
Reduced
41
Closed
22
Calls
$3.51M
Puts
$4.49M
Net Calls
-$978K
Net Calls Change
-$2.1M
Name Holding Trade Value Shares
Change
Change in
Stake
GTC
26
Ghost Tree Capital
New York
$12.9M +$11.1M +475,000 New
Deutsche Bank
27
Deutsche Bank
Germany
$12.1M +$190K +8,121 +2%
Prudential Financial
28
Prudential Financial
New Jersey
$9.3M -$2.41M -103,341 -23%
GKIM
29
GW&K Investment Management
Massachusetts
$8.84M -$236K -10,129 -3%
Federated Hermes
30
Federated Hermes
Pennsylvania
$7.23M +$4.59M +196,422 +285%
PPA
31
Parametric Portfolio Associates
Washington
$5.51M +$497K +21,309 +12%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$5.33M +$96K +4,112 +2%
Axa
33
Axa
France
$5.18M
Bank of Montreal
34
Bank of Montreal
Ontario, Canada
$4.78M -$480K -20,549 -11%
Thrivent Financial for Lutherans
35
Thrivent Financial for Lutherans
Minnesota
$4.48M +$2.47M +105,861 +181%
PAI
36
Palo Alto Investors
California
$4.3M
Two Sigma Advisers
37
Two Sigma Advisers
New York
$4.29M -$546K -23,400 -13%
PCH
38
Polar Capital Holdings
United Kingdom
$3.41M +$2.92M +125,000 New
SSA
39
Schonfeld Strategic Advisors
New York
$3.35M +$2.87M +122,819 New
ORI
40
Oak Ridge Investments
Illinois
$3.33M -$742K -31,777 -21%
Wells Fargo
41
Wells Fargo
California
$3.06M +$349K +14,948 +15%
RHJA
42
Rice Hall James & Associates
California
$3.05M +$2.61M +111,864 New
Massachusetts Financial Services
43
Massachusetts Financial Services
Massachusetts
$3.02M -$25.9K -1,108 -1%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$2.99M -$22K -944 -0.9%
DS
45
DRW Securities
Illinois
$2.73M -$467K -20,000 -17%
Swiss National Bank
46
Swiss National Bank
Switzerland
$2.67M +$49K +2,100 +2%
AA
47
ALPS Advisors
Colorado
$2.51M +$2.15M +92,012 New
State Board of Administration of Florida Retirement System
48
State Board of Administration of Florida Retirement System
Florida
$2.46M
Allianz Asset Management
49
Allianz Asset Management
Germany
$2.28M +$315K +13,507 +19%
PCM
50
Prelude Capital Management
New York
$2.17M -$1.3M -55,552 -41%

TVTX Hedge Fund Activity: Q4 2020 in Review

138 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Travere Therapeutics (TVTX) for Q4 2020, worth a combined $1.42B — up 51% from $945M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new TVTX positions and 22 closed out — a net gain of 6 holders — while 48 added to existing stakes and 41 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $30.7M. The largest seller was State Street, exiting entirely with an estimated $35.5M sold.

  • 138 institutional investors held Travere Therapeutics (TVTX) as of Q4 2020, up from 134 in Q3 2020.
  • Funds reported $1.42B of Travere Therapeutics stock for Q4 2020, up 51% quarter-over-quarter.
  • 28 funds opened new Travere Therapeutics positions in Q4 2020 and 22 closed out, a net change of +6 holders.
  • The largest Travere Therapeutics buyer in Q4 2020 was Adage Capital Partners, an estimated $30.7M added.
  • The largest Travere Therapeutics seller in Q4 2020 was State Street, an estimated $35.5M sold.

Based on aggregated 13F filings for Q4 2020.